scFv Antibody Fragments for Gal-α-(1→3)-Gal Epitope Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and quantifying the Gal-α-(1→3)-Gal epitope are cumbersome, time-consuming, and require specialist equipment, limiting their application in monitoring recombinant therapeutics and transplantation tissues for rejection complications and immunogenic responses.
Innovation Solution
Development of high-affinity, specific single-chain antibody fragments (scFvs) generated from chicken libraries, which can be used in direct and competitive ELISA assays for rapid detection and quantification of the Gal-α-(1→3)-Gal epitope on recombinant proteins and tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If HPLC coupled with mass spectrometry and endoglycosidase digestion is used for detection, then measurement precision is improved, but device complexity and time consumption increase
Solution Approach 1:
The patent extracts the detection function from complex HPLC-MS systems and implements it using simple ELISA assays with engineered scFv antibodies. The scFvs specifically bind to Gal-α-(1→3)-Gal epitopes, enabling direct detection without requiring complex glycan release and analysis equipment.
Solution Approach 2:
The patent replaces the mechanical/physical separation and detection system (HPLC-MS) with a biochemical recognition system (scFv-ELISA). The engineered antibodies provide specific molecular recognition of the epitope, substituting complex instrumental analysis with a simpler immunological assay.
2Measurement precision
If HPLC coupled with mass spectrometry is used for quantification, then measurement precision is improved, but loss of time increases
Solution Approach 1:
The scFv antibodies are pre-engineered with high affinity and specificity for the Gal-α-(1→3)-Gal epitope before use. This preliminary optimization of binding characteristics allows rapid detection without requiring time-consuming method development or complex sample preparation protocols.
3Measurement precision
If specialist equipment is required for detection, then measurement precision is improved, but ease of operation deteriorates
Solution Approach 1:
The patent employs disposable ELISA plates and simple reagent systems that can be discarded after use, replacing expensive, complex, and difficult-to-operate HPLC-MS equipment. The scFv-based assay uses readily available laboratory materials, making it accessible to routine laboratories without specialized instrumentation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The scFvs demonstrate high specificity and sensitivity, enabling effective detection of the Gal-α-(1→3)-Gal epitope at low ng/ml levels, surpassing the limitations of existing methods and providing a convenient, point-of-care solution for monitoring immunogenic responses and therapeutic efficacy.
Implementation Method 1
an antibody having a variable light chain sequence and a variable heavy chain sequence... capable of binding selectively to the Gal-α-(1→3)-Gal epitope
Data Source
AI summary
The present invention relates to the provision of antibody fragments capable of binding selectively to the Gal-α-(1→3)-Gal epitope. The invention further relates to assay systems comprising these antibody fragments for use in testing transplantation tissue for possible rejection complications. This epitope is often found on porcine tissue destined for human transplantation. The epitope is also found on biopharmaceuticals and on some infectious agents and accordingly the invention also provides assay systems for these applications.